Save the Date for the Second Annual Boston Society Medical Symposium on Acute Myeloid Leukemia (AML)
October 4, 2019

Broad Institute of MIT and Harvard 
415 Main Street 
Cambridge, MA 02142

Invited Speakers 

 

Daniel J. DeAngelo, MD, PhD, Associate Professor, Medicine, Harvard Medical School

Current Landscape for the Treatment of Patients with Acute Myloid  Leukeia

 

 

Terry Fry, MD, Professor of Pediatrics, Hematology and Immunology, Children's Hospital Colorado

Immunotherapies for AML - title TBA

             
 

Jacqueline S. Garcia, MD, Physician, DFCI, Instructor in Medicine, Harvard Medical School

BCL2 - title TBA

     

Gwen Nichols, MD, Chief Medical Officer, The Leuklemia & Lymphoma Society

LLS Children's Innitiative

 

             
   

Kelly Norsworthy MD, FDA, (DHHS/ FDA/CDER/ OMPT/CDER/ OND/OHOP/DHP)

Public-Private Partnership on AML

     

Kimberly Stegmaier MD, Professor of Pediatrics, Harvard Medical School, Ted Williams Investigator, Dana-Farber Cancer Institute 

Pediatric AML-title TBA

             
 

Patrick Zweidler-McKay, MD, PhD, Medical Director for Hematologic Malignancies, ImmunoGen

Title TBA

       
             

 AML 2019 Sessions 

Session I:  The Current Landscape - Updates

Session II:  State of the Art Research and Treatment Options - Updates

Session III:  On the Horizon

 

 

 Join our Linkedin Group:

Sessions

Session I:  The Current Landscape - Updates

Session II:  Session II - State of the Art Research and Treatment Updates

Session III:  On the Horizon

Registration

Click here to register for the AML 2019 conference online.

AML 2019 will take place

October 4, 2019

Broad Institute

Cambridge, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy